Science Explorer Back to mapMap
Discussion
Researcher · Synthon (Netherlands) · Netherlands

Wim H.A. Dokter

Wim H.A. Dokter publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Cytokine Signaling Pathways and Interactions.

ORCID 0000-0002-0181-3877 OpenAlex
World rank
#917,150
of 7,710,434 ranked researchers
Rank in Netherlands
#21,620
of 107,149
Works
123
Citations
2.1k
Citations per work
16.7
h-index
22
i10-index 34Top 20% in Oncology
Wim H.A. Dokter

What does Wim H.A. Dokter research?

Wim H.A. Dokter's work is mostly in Medicine (42%), Immunology and Microbiology (14%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 51 works · 41.8% of their workMedicine: 51 works · 41.8% of their workOncology: 25 works · 20.4% of their workRadiology, Nuclear Medicine and Imaging: 12 works · 9.9% of their workEndocrinology, Diabetes and Metabolism: 9 works · 7.3% of their workEpidemiology: 5 works · 4.2% of their workEverything else: 43 works · 34.7% of their workLife Sciences: 29 works · 23.5% of their workImmunology and Microbiology: 17 works · 13.6% of their workImmunology: 17 works · 13.6% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 9.9% of their workMolecular Biology: 12 works · 9.9% of their workTHEIR WORKWim H.A. Dokter123works
Life Sciences24%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5141.8%
  2. Everything else4334.7%
    1. Immunology and Microbiology1713.6%
    2. Biochemistry, Genetics and Molecular Biology129.9%
  1. 1Oncology20% of their works
  2. 2Immunology14% of their works
  3. 3Molecular Biology10% of their works
  4. 4Radiology, Nuclear Medicine and Imaging10% of their works
  5. 5Endocrinology, Diabetes and Metabolism7% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Wim H.A. Dokter's research?

The keywords of their largest research topics: Fc Receptors, Therapeutic Antibodies, Cancer Immunotherapy, Breast Cancer, HER2, Cancer, Inflammation and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Fc Receptors181 topic
  2. Therapeutic Antibodies181 topic
  3. Cancer Immunotherapy153 topics
  4. Breast Cancer141 topic
  5. HER2141 topic
  6. Cancer122 topics
  7. Inflammation122 topics
  8. Immunity92 topics
  9. IL-681 topic
  10. STAT381 topic
  11. Aldosterone61 topic
  12. Primary Aldosteronism61 topic
  13. Antigen Presentation51 topic
  14. CAR T Cells51 topic
  15. CD4751 topic
  16. Chimeric Antigen Receptor51 topic
  17. Dendritic Cells51 topic
  18. apoptotic cells51 topic
  19. NF-?B41 topic
  20. Signaling41 topic

Where does Wim H.A. Dokter work?

Wim H.A. Dokter's main affiliation in the publication record is Synthon (Netherlands), Netherlands.

How many publications and citations does Wim H.A. Dokter have?

OpenAlex counts 123 works and 2,058 citations for Wim H.A. Dokter, an h-index of 22, ranking #917,150 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Wim H.A. Dokter. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.